Angina Market Share

ID: MRFR/Pharma/4293-HCR

90 Pages

Rahul Gotadki

October 2025

Angina Market Research Report, by Type (Angina Pectoris), Diagnosis (Imaging, Stress Test), Treatment (Lifestyle, Medications, Angioplasty, and Stenting), End-Users (Hospital & Clinics, Diagnostic Centers, Academic Institutes)–Forecast Till 2035

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Download PDF

Market Share

Angina Market Share Analysis

Distinguish the ideal interest group inside the angina market, including patients, cardiologists, general experts, medical clinics, and medical care payers. Fragment the market considering elements like age, orientation, comorbidities, and treatment history to as needs be tailoring situating systems. Separate angina treatment choices from contenders by offering remarkable plans, conveyance techniques, or systems of activity. Feature elements like quick side effect help, further developed practice resistance, decreased chance of cardiovascular occasions, or improved wellbeing profile to address explicit patient requirements and inclinations. Obviously impart the incentive of angina items or administrations to patients, medical care suppliers, and payers. Stress advantages, for example, side effect control, personal satisfaction improvement, diminished hospitalizations, and cost-adequacy to resound with their treatment objectives and assumptions. Decisively value angina items or administrations considering variables like treatment viability, brand notoriety, and serious scene. Offer worth based estimating procedures, limits, or patient help projects to further develop reasonableness and access for patients. Put resources into clinical exploration to create vigorous proof supporting the adequacy and security of angina items or administrations. Use this information for proof-based marketing efforts focusing on medical services suppliers and patients to fabricate believability and trust. Constantly screen market elements, contender exercises, and patient input to in like manner adjust situating procedures. Remain receptive to arising patterns, administrative changes, and client needs to keep an upper hand.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future Analysis, the Global Angina Market was valued at USD 0.52 Billion in 2023 and is projected to grow to USD 2.13 Billion by 2032, with a CAGR of 5.52% from 2024 to 2032. Angina, a symptom of coronary artery disease, is characterized by chest pain due to reduced blood flow to the heart. The market growth is driven by the increasing prevalence of angina, rising healthcare expenditure, and a growing geriatric and obese population. However, challenges such as low per capita healthcare expenditure and high costs of therapeutic procedures may restrain growth. Recent developments include Auxilius Pharma's upcoming Phase Ib trial for AUX-001 and Zydus Lifesciences' approval for Isosorbide Mononitrate extended-release tablets.

Key Market Trends & Highlights

The angina market is witnessing significant developments and growth opportunities.

Market Size in 2023: USD 0.52 Billion.
Projected Market Size by 2032: USD 2.13 Billion.
CAGR from 2024 to 2032: 5.52%.
Prevalence of angina in West Virginia: 6.2%.

Market Size & Forecast

2023 Market Size	USD 0.52 Billion
2024 Market Size	USD 0.72 Billion
2032 Market Size	USD 2.13 Billion
CAGR (2024-2032)	5.52%.

Major Players

Anthera (U.S.), Taxus Cardium (U.S.), Astellas Pharma (Japan), Sanofi (France), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Torrent Pharmaceuticals Limited (India), Huya Bioscience International (U.S.), Viromed Co. Ltd. (South Korea), Baxter (U.S.)

Market Trends

The increasing prevalence of cardiovascular diseases globally suggests a rising demand for effective angina management solutions, highlighting the need for innovative therapeutic approaches.

World Health Organization (WHO)

Angina Market Market Drivers

Aging Population

The demographic shift towards an aging population is a significant factor impacting the Global Global Angina Market Industry. Older adults are at a higher risk for developing cardiovascular diseases, including angina, due to age-related physiological changes. As the global population ages, particularly in developed nations, the demand for angina-related healthcare services and products is expected to rise. This demographic trend suggests a sustained increase in market size, as healthcare systems adapt to meet the needs of this growing patient demographic.

Market Growth Projections

The Global Global Angina Market Industry is projected to witness substantial growth over the coming years. With an estimated market value of 0.72 USD Billion in 2024, it is expected to expand to 2.5 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate of 11.99% from 2025 to 2035, reflecting the increasing demand for effective angina treatments and management solutions. The market's expansion is likely to be fueled by various factors, including advancements in medical technology, rising prevalence of cardiovascular diseases, and supportive regulatory frameworks.

Growing Awareness and Education

There is a notable increase in awareness and education regarding cardiovascular health, which is influencing the Global Global Angina Market Industry. Public health campaigns and educational initiatives are effectively informing individuals about the symptoms and risks associated with angina. This heightened awareness encourages early diagnosis and treatment, thereby driving market growth. As more patients seek medical advice upon experiencing symptoms, healthcare providers are prompted to offer a wider range of treatment options, further expanding the market's potential.

Advancements in Medical Technology

Technological innovations in medical devices and pharmaceuticals are propelling the Global Global Angina Market Industry forward. New diagnostic tools and treatment options, such as advanced stents and drug-eluting technologies, enhance patient outcomes and improve the management of angina. These advancements not only facilitate early detection but also enable more personalized treatment approaches. As healthcare systems worldwide adopt these technologies, the market is likely to experience substantial growth, driven by the increasing availability of effective therapies that cater to diverse patient needs.

Regulatory Support and Initiatives

Government initiatives and regulatory support play a crucial role in shaping the Global Global Angina Market Industry. Policies aimed at improving cardiovascular health and funding for research into new treatments are fostering an environment conducive to market growth. Regulatory bodies are increasingly approving innovative therapies and devices, which enhances treatment options available to patients. This supportive regulatory landscape is likely to encourage investment in research and development, further driving advancements in angina management.

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases globally is a primary driver of the Global Global Angina Market Industry. As lifestyle-related factors such as poor diet, lack of physical activity, and rising obesity rates contribute to heart conditions, the demand for angina management solutions intensifies. In 2024, the market is projected to reach 0.72 USD Billion, reflecting the urgent need for effective treatments. This trend is expected to continue, with the market anticipated to grow significantly, potentially reaching 2.5 USD Billion by 2035, indicating a robust compound annual growth rate of 11.99% from 2025 to 2035.

Market Segment Insights

Regional Insights

Key Companies in the Angina Market market include

Industry Developments

Future Outlook

Angina Market Future Outlook

The Global Angina Market is projected to grow at 11.99% CAGR from 2024 to 2035, driven by advancements in treatment options, increasing prevalence, and enhanced patient awareness.

New opportunities lie in:

Develop innovative telehealth solutions for remote angina management.
Invest in research for novel pharmacological therapies targeting angina symptoms.
Expand distribution networks in emerging markets to increase access to angina treatments.

By 2035, the Global Angina Market is expected to exhibit robust growth, reflecting significant advancements and increased market penetration.

Market Segmentation

Global Angina Market Segmentation

Key Players in the Angina Market

Anthera (U.S.)
Taxus Cardium (U.S.)
Astellas Pharma (Japan)
Sanofi (France)
Bayer AG (Germany)
., Inc. (U.S.)
Torrent Pharmaceuticals Limited (India)
Huya Bioscience International (U.S.)
Viromed Co. Ltd. (South Korea)
Baxter (U.S.)

Report Scope

Report Attribute/Metric

Details

Market Size 2023	0.52 (USD Billion)
Market Size 2024	0.72 (USD Billion)
Market Size 2032	2.13 (USD Billion)
Compound Annual Growth Rate (CAGR)	5.52 % (2024 - 2032)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2023
Market Forecast Period	2024 - 2032
Historical Data	2019 - 2023

Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Types, end user, Region

Geographies Covered

America, Europe, Asia Pacific, Middle East and Africa

Key Vendors

Market Highlights

Author

Rahul Gotadki

Assistant Manager

She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Latest Comments

John Doe

john@example.com

This is a great article! Really helped me understand the topic better.

Posted on July 23, 2025, 10:15 AM

Jane Smith

jane@domain.com

Thanks for sharing this. I’ve bookmarked it for later reference.

Posted on July 22, 2025, 7:45 PM

View All

FAQs

What is Angina?

Angina is a significant symptom of coronary artery disease and can be described as squeezing, tightness, and heaviness of the chest. It is a type of chest pain caused by a reduced flow of blood to the heart.

What is the CAGR of the Angina Market?

Global Angina Market is expected to exhibit a strong 5.52% CAGR over the forecast period till 2032.

What is the major driver for the Angina Market?

The growing prevalence of cardiovascular diseases is the major driver for the global angina market.

Which is the major regional Angina Market?

The Americas dominate the Global Angina Market.

What are the key players in the Angina Market?

Leading players in the Angina Market include Bayer AG, Sanofi, and Astellas Pharma, among others.

TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
1. Definition
2. Scope of the Study
  1. Research Objective
  2. Assumptions
  3. Limitations
Chapter 3. Research Methodology
1. Introduction
2. Primary Research
3. Secondary research
4. Market Size Estimation
Chapter 4. Market Dynamics
1. Drivers
2. Restrains
3. Opportunities
4. Challenges
5. Macroeconomic Indicators
6. Technology Trends & Assessment
Chapter 5. Market Factor Analysis
1. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
2. Value Chain Analysis
3. Investment Feasibility Analysis
4. Pricing Analysis
Chapter 6. Global Angina Market, by Type
6.1 Introduction
1. Angina Pectoris
Market Estimates & Forecast, 2020–2027
1. Unstable Angina
2. Prinzmetal Angina
3. Others
Chapter 7. Global Angina Market, by Diagnosis
7.1 Introduction
1. Imaging
Market Estimates & Forecast, 2020–2027
1. Electrocardiogram
  1. Chest X-ray
  2. Cardiac Computerized Tomography Scan
  3. Cardiac MRI
  4. Others
2. Blood Tests
  1. Cholesterol Test
  2. Low-Density Lipoprotein Test
  3. Triglycerides Test
  4. Others
3. Stress Test
4. Others
Chapter 8. Global Angina Market, by Treatment
1. Introduction
2. Lifestyle Changes
3. Medications
  1. Aspirin
  2. Clot-Preventing Drugs
Market Estimates & Forecast, 2020–2027
1. Clopidogrel
  1. Prasugrel
  2. Statins
  3. Ranolazine
  4. Others
2. Angioplasty and Stenting
3. Coronary Bypass Surgery
Market Estimates & Forecast, 2020–2027
1. Others
Chapter 9. Global Angina Market, by End-User
1. Introduction
2. Hospital & Clinics
3. Diagnostic Centers
4. Academic Institutes
5. Others
Chapter 10. Global Angina Market, by Region
1. Introduction
2. America
  1. North America
  2. South America
3. Europe
  1. Western Europe
  2. Eastern Europe
4. Asia Pacific
  1. Japan
  2. China
  3. India
  4. Australia
  5. Republic of Korea
  6. Rest of Asia Pacific
5. The Middle East & Africa
  1. United Arab Emirates
  2. Saudi Arabia
  3. Oman
  4. Kuwait
  5. Qatar
  6. Rest of the Middle East & Africa
Chapter 11. Company Landscape
1. Introduction
2. Market Share Analysis
3. Key Development & Strategies
  1. Key Developments
Chapter 12 Company Profiles
1. Anthera
  1. Company Overview
  2. Type Overview
  3. Financials
  4. Key Developments
  5. SWOT Analysis
2. Taxus Cardium
  1. Company Overview
  2. Type Overview
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
3. Astellas Pharma
  1. Company Overview
  2. Type Overview
  3. Financial Overview
  4. Key Development
  5. SWOT Analysis
4. Sanofi
  1. Company Overview
  2. Type/Business Segment Overview
  3. Financial Overview
  4. Key Development
  5. SWOT Analysis
5. Bayer AG
  1. Company Overview
  2. Type Overview
  3. Financial overview
  4. Key Developments
  5. SWOT Analysis
6. Merck & Co., Inc.
  1. Company Overview
  2. Type Overview
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
7. Torrent Pharmaceuticals
  1. Overview
  2. Type Overview
  3. Financials
  4. Key Developments
  5. SWOT Analysis
12.8 Huya Bioscience International
1. Overview
  1. Type Overview
  2. Financials
  3. Key Developments
  4. SWOT Analysis
2. Viromed Co. Ltd.
  1. Overview
  2. Type Overview
  3. Financials
  4. Key Developments
  5. SWOT Analysis
3. Baxter
  1. Overview
  2. Type Overview
  3. Financials
  4. Key Developments
  5. SWOT Analysis
4. Others
Chapter 13 MRFR Conclusion
1. Key Findings
  1. From CEO’s View Point
  2. Unmet Needs of the Market
2. Key Companies to Watch
3. Prediction of Angina Market
Chapter 14 Appendix
List of Tables and Figures
1. LIST OF TABLES
2. Table 1 Angina Industry Synopsis, 2020–2027
3. Table 2 Global Angina Market Estimates & Forecast, 2020–2027, (USD Million)
4. Table 3 Global Angina Market, by Region, 2020–2027, (USD Million)
5. Table 4 Global Angina Market, by Type, 2020–2027, (USD Million)
6. Table 5 Global Angina Market, by Diagnosis, 2020–2027, (USD Million)
7. Table 6 Global Angina Market, by Treatment, 2020–2027, (USD Million)
8. Table 7 Global Angina Market, by End-User, 2020–2027, (USD Million
9. Table 8 North America Angina Market, by Type, 2020–2027, (USD Million)
10. Table 9 North America Angina, by Diagnosis, 2020–2027, (USD Million)
11. Table 10 North America Angina, by Treatment, 2020–2027, (USD Million)
12. Table 11 North America Angina, by End-User, 2020–2027, (USD Million)
13. Table 12 U.S. Angina Market, by Type, 2020–2027, (USD Million)
14. Table 13 U.S. Angina Market, by Diagnosis, 2020–2027, (USD Million)
15. Table 14 U.S. Angina Market, by Treatment, 2020–2027, (USD Million)
16. Table 15 U.S. Angina Market, by End-User, 2020–2027, (USD Million)
17. Table 16 Canada Angina Market, by Type, 2020–2027, (USD Million)
18. Table 17 Canada Angina Market, by Diagnosis, 2020–2027, (USD Million)
19. Table 18 Canada Angina Market, by Treatment, 2020–2027, (USD Million)
20. Table 19 Canada Angina Market, by End-User, 2020–2027, (USD Million)
21. Table 20 South America Angina Market, by Type, 2020–2027, (USD Million)
22. Table 21 South America Angina Market, by Diagnosis, 2020–2027, (USD Million)
23. Table 22 South America Angina Market, by Treatment, 2020–2027, (USD Million)
24. Table 23 South America Angina Market, by End-User, 2020–2027, (USD Million)
25. Table 24 Europe Angina Market, by Type, 2020–2027, (USD Million)
26. Table 25 Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)
27. Table 26 Europe Angina Market, by Treatment, 2020–2027, (USD Million)
28. Table 27 Europe Angina Market, by End-User, 2020–2027, (USD Million)
29. Table 28 Western Europe Angina Market, by Type, 2020–2027, (USD Million)
30. Table 29 Western Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)
31. Table 30 Western Europe Angina Market, by Treatment, 2020–2027, (USD Million)
32. Table 31 Western Europe Angina Market, by End-User, 2020–2027, (USD Million)
33. Table 32 Eastern Europe Angina Market, by Type, 2020–2027, (USD Million)
34. Table 33 Eastern Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)
35. Table 34 Eastern Europe Angina Market, by Treatment, 2020–2027, (USD Million)
36. Table 35 Eastern Europe Angina Market, by End-User, 2020–2027, (USD Million)
37. Table 36 Asia Pacific Angina Market, by Type, 2020–2027, (USD Million)
38. Table 37 Asia Pacific Angina Market, by Diagnosis, 2020–2027, (USD Million)
39. Table 38 Asia Pacific Angina Market, by Treatment, 2020–2027, (USD Million)
40. Table 39 Asia Pacific Angina Market, by End-User, 2020–2027, (USD Million)
41. Table 40 The Middle East & Africa Angina Market, by Type, 2020–2027, (USD Million)
42. Table 41 The Middle East & Africa Angina Market, by Diagnosis, 2020–2027, (USD Million)
43. Table 42 The Middle East & Africa Angina Market, by Treatment, 2020–2027, (USD Million)
44. Table 43 The Middle East & Africa Angina Market, by End-User, 2020–2027, (USD Million) LIST OF FIGURES
45. Figure 1 Research Process
46. Figure 2 Segmentation for Global Angina Market
47. Figure 3 Market Dynamics for Global Angina Market
48. Figure 4 Global Angina Market Share, by Type 2020
49. Figure 5 Global Angina Market Share, by Diagnosis 2020
50. Figure 6 Global Angina Market Share, by Treatment, 2020
51. Figure 7 Global Angina Market Share, by End-User, 2020
52. Figure 8 Global Angina Market Share, by Region, 2020
53. Figure 9 North America Angina Market Share, by Country, 2020
54. Figure 10 Europe Angina Market Share, by Country, 2020
55. Figure 11 Asia Pacific Angina Market Share, by Country, 2020
56. Figure 12 The Middle East & Africa Angina Market Share, by Country, 2020
57. Figure 13 Global Angina Market: Company Share Analysis, 2020 (%)
58. Figure 14 Anthera: Key Financials
59. Figure 15 Anthera: Segmental Revenue
60. Figure 16 Anthera: Geographical Revenue
61. Figure 17 Taxus Cardium: Key Financials
62. Figure 18 Taxus Cardium: Segmental Revenue
63. Figure 19 Taxus Cardium: Geographical Revenue
64. Figure 20 Astellas Pharma: Key Financials
65. Figure 21 Astellas Pharma: Segmental Revenue
66. Figure 22 Astellas Pharma: Geographical Revenue
67. Figure 23 Sanofi: Key Financials
68. Figure 24 Sanofi: Segmental Revenue
69. Figure 25 Sanofi: Geographical Revenue
70. Figure 26 Bayer AG: Key Financials
71. Figure 27 Bayer AG: Segmental Revenue
72. Figure 28 Bayer AG: Geographical Revenue
73. Figure 29 Merck & Co., Inc.: Key Financials
74. Figure 30 Merck & Co., Inc.: Segmental Revenue
75. Figure 31 Merck & Co., Inc.: Geographical Revenue
76. Figure 32 Torrent Pharmaceuticals Limited: Key Financials
77. Figure 33 Torrent Pharmaceuticals Limited: Segmental Revenue
78. Figure 34 Torrent Pharmaceuticals Limited: Geographical Revenue
79. Figure 35 Huya Bioscience International: Key Financials
80. Figure 36 Huya Bioscience International: Segmental Revenue
81. Figure 37 Huya Bioscience International: Geographical Revenue
82. Figure 38 Viromed Co. Ltd.: Key Financials
83. Figure 39 Viromed Co. Ltd.: Segmental Revenue
84. Figure 40 Viromed Co. Ltd.: Geographical Revenue
85. Figure 41 Baxter: Key Financials
86. Figure 42 Baxter: Segmental Revenue
87. Figure 43 Baxter: Geographical Revenue

Angina Market Segmentation

Market Segmentation Overview

Detailed segmentation data will be available in the full report
Comprehensive analysis by multiple parameters
Regional and country-level breakdowns
Market size forecasts by segment

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027